prostate-report.org

Photoselective vaporization prostatectomy

A group at the University of Oklahoma has reported the incidence, prevention, and management of perioperative adverse events in patients treated with transurethral photoselective vaporization prostatectomy (PVP) using the side-firing GreenLight HPS laser.

Among other, the authors report the following outcome data

1. Postoperative adverse events included clinically non-significant hematuria in 55/70 patients (78.5 percent), hematuria requiring clot evacuation in 1/70 patients (1.4 percent), urinary retention requiring recatheterization in 2/70 patients (2.8 percent), urinary tract infection in 3/70 patients (4.3 percent), and prostatitis in 1/70 patients (1.4 percent).
2. No urethral strictures, bladder neck contracture, or urinary incontinence were noted.

The authors conclude that, on the basis of these data, GreenLight HPS laser PVP appears to have a low incidence of perioperative adverse events.